Experimentation to favor innovation: Promoting the success of Article 51 transformation projects.


Journal

Therapie
ISSN: 0040-5957
Titre abrégé: Therapie
Pays: France
ID NLM: 0420544

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 06 11 2018
accepted: 12 11 2018
pubmed: 27 1 2019
medline: 18 12 2019
entrez: 27 1 2019
Statut: ppublish

Résumé

Article 51 of the French social security financing act for 2018 creates a derogatory funding system to support experimentation with new ways of organizing care pathways. The growing interest local leaders have expressed for this very open framework has led to a large number of candidate projects presented to public authorities in charge of the system. In order to sustain this dynamic movement and favor the success of these experimental projects, our work focused on clarifying the roles and responsibilities of project leaders and the need for a specific evaluation system that takes into account the evolving nature of these projects and the need for operational adaptability. We propose three levels of evaluation (feasibility, intermediary results and impact assessment) needed to decide on generalizing a given experiment based on its intermediary results, or on the contrary, terminating projects not meeting feasibility expectations. Our work emphasizes the importance of networking and of developing favorable conditions for fruitful collaboration between participating stakeholders-healthcare professionals, health providers, economic partners, learned societies-interested in improving the performance of care pathways.

Identifiants

pubmed: 30683444
pii: S0040-5957(18)30258-0
doi: 10.1016/j.therap.2018.11.010
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

51-57

Investigateurs

Jean Bourhis (J)
Sandrine Bourguignon (S)
Benoît Dervaux (B)
Sophie Dubois (S)
Isabelle Durand-Zaleski (I)
Anne-Aurélie Epis de Fleurian (AA)
Florence Favrel-Feuillade (F)
Philippe Lechat (P)
Philippe Maugendre (P)
Bastien Mezerette (B)
Dominique Polton (D)
Xavier Pourrat (X)

Informations de copyright

Copyright © 2018 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Adeline Townsend (A)

Ministère de la santé, 75007 Paris, France.

Hervé de Trogoff (H)

Astellas Pharma, 26, quai Charles-Pasqua, CS90067, 92309 Levallois-Perret, France. Electronic address: herve.detrogoff@astellas.com.

Karine Szwarcensztein (K)

Johnson & Johnson Medical, 92130 Issy-Les-Moulineaux, France.

Articles similaires

1.00
Humans Personnel Staffing and Scheduling Nursing Staff, Hospital Male Adult
Humans Male Female Health Knowledge, Attitudes, Practice Middle Aged
Humans Peripheral Arterial Disease Retrospective Studies Male Female

Classifications MeSH